-
公开(公告)号:US11236142B2
公开(公告)日:2022-02-01
申请号:US16638970
申请日:2018-08-16
申请人: DONG-A ST CO., LTD.
发明人: Jae-Sung Yang , Kyung-Seok Lee , Yu-Na Chae , Gye-Rim Baek , Tae-Hyoung Kim , Ill-Hun Jung , Chae-Lim Ryu , Weon-Bin Im
IPC分类号: A61K38/00 , C07K14/575 , A61P3/04 , A61P3/10
摘要: The present invention relates to a novel peptide analog of acylated oxyntomodulin and a pharmaceutical composition comprising the same for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptides are superior to those of natural oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition comprising said peptides is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
-
2.
公开(公告)号:US20160168167A1
公开(公告)日:2016-06-16
申请号:US14908006
申请日:2014-07-28
申请人: DONG-A ST CO., LTD.
发明人: Soon-Hoe Kim , Weon-Bin Im , Seung-Bum Ha , Jung-Sang Park , Mi-Yeon Kim , Sung-Hak Choi , Hyun-Jung Sung
IPC分类号: C07F5/02
摘要: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.
摘要翻译: 本发明涉及一种新型的三环苯并恶灵衍生物及其制备方法,以及使用包含其的活性成分的抗生素药物组合物。
-
公开(公告)号:US11713344B2
公开(公告)日:2023-08-01
申请号:US17410697
申请日:2021-08-24
申请人: DONG-A ST CO., LTD.
发明人: Jae-Sung Yang , Kyung-Seok Lee , Yu-Na Chae , Gye-Rim Baek , Tae-Hyoung Kim , Ill-Hun Jung , Chae-Lim Ryu , Weon-Bin Im
IPC分类号: C07K14/575 , A61P3/04 , A61P3/10 , A61K38/00
CPC分类号: C07K14/575 , A61P3/04 , A61P3/10 , A61K38/00
摘要: A novel peptide analog of acylated oxyntomodulin and its uses are disclosed. A pharmaceutical composition containing the novel peptide analog is useful and effective for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptide analog and a composition containing the peptide analog are superior to those of wild-type oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition containing the peptide analog is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
-
公开(公告)号:US20180086709A1
公开(公告)日:2018-03-29
申请号:US15718474
申请日:2017-09-28
申请人: Dong-A St Co., Ltd.
发明人: Sun-Ho Choi , Weon-Bin Im , Sung-Hak Choi , Chong-Hwan Cho , Ho-Sang Moon , Jung-Sang Park , Min-Jung Lee , Hyun-Jung Sung , Jun-Hwan Moon , Seung-Hyun Song , Hyung-Keun Lee , Ji-Hoon Choi , Cheon-Hyoung Park , Yoon-Jung Kim , Jin-Hyuk Kim
IPC分类号: C07D211/70 , C07D401/10 , C07D409/10 , C07D405/10 , C07D401/04
CPC分类号: C07D211/70 , C07D401/04 , C07D401/10 , C07D405/10 , C07D409/10
摘要: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.
-
公开(公告)号:US10160724B2
公开(公告)日:2018-12-25
申请号:US15718474
申请日:2017-09-28
申请人: Dong-A St Co., Ltd.
发明人: Sun-Ho Choi , Weon-Bin Im , Sung-Hak Choi , Chong-Hwan Cho , Ho-Sang Moon , Jung-Sang Park , Min-Jung Lee , Hyun-Jung Sung , Jun-Hwan Moon , Seung-Hyun Song , Hyung-Keun Lee , Ji-Hoon Choi , Cheon-Hyoung Park , Yoon-Jung Kim , Jin-Hyuk Kim
IPC分类号: C07D211/70 , C07D401/04 , C07D401/10 , C07D405/10 , C07D409/10
摘要: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.
-
公开(公告)号:US09828339B2
公开(公告)日:2017-11-28
申请号:US14909096
申请日:2014-07-17
申请人: DONG-A ST CO., LTD
发明人: Soon-Hoe Kim , Weon-Bin Im , Chong-Hwan Cho , Sun-Ho Choi , Jung-Sang Park , Mi-Yeon Kim , Sung-Hak Choi , Min-Jung Lee , Kang-Hun Cho
IPC分类号: C07D207/08
CPC分类号: C07D207/08
摘要: Provided are biphenyl derivatives having the structure of Formula 1: stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein R1 is hydrogen, halogen, hydroxy, substituted or unsubstituted C1-C6 alkyl, or C1-C6 alkoxy; R2, R3 and R4 are each independently hydrogen, halogen, substituted or unsubstituted amino, nitro, cyano, hydroxy, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 alkoxy, or —C(O)R6; R5 is hydrogen or C1-C6 alkyl; n is 0 or 1; and R6 is hydrogen or amino, methods for preparing the same, and a pharmaceutical composition containing the same. The biphenyl derivatives having the structure of Formula 1 act as muscarinic M3 receptor antagonists, and thus are useful for the prevention or treatment of a disease selected from among chronic obstructive pulmonary disease, asthma, irritable bowel syndrome, urinary incontinence, rhinitis, spasmodic colitis, chronic cystitis, Alzheimer's disease, senile dementia, glaucoma, schizophrenia, gastroesophageal reflux disease, cardiac arrhythmia, and hyper-salivation syndromes.
-
公开(公告)号:US09676796B2
公开(公告)日:2017-06-13
申请号:US14908006
申请日:2014-07-28
申请人: DONG-A ST CO., LTD.
发明人: Soon-Hoe Kim , Weon-Bin Im , Seung-Bum Ha , Jung-Sang Park , Mi-Yeon Kim , Sung-Hak Choi , Hyun-Jung Sung
摘要: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.
-
-
-
-
-
-